# reload+after+2024-01-21 11:47:27.634693
address1§100 Washington Boulevard
city§Stamford
state§CT
zip§06902
country§United States
phone§203 883 9490
website§https://www.springworkstx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III DeFi trial for the treatment of desmoid tumors. The company is also developing mirdametinib, an oral small molecule MEK inhibitor that is in Phase 2b clinical trials for the treatment of neurofibromatosis type 1-associated plexiform neurofibromas, as well as Phase 1/2a clinical trial for the treatment of NF1-PN; mirdametinib + lifirafenib, a combination therapy that is in Phase 1b/2 clinical trial in patients with advanced or refractory solid tumors; and mirdametinib in monotherapy and combination approaches to treat solid tumors. In addition, it develops BGB-3245, an oral selective small molecule inhibitor of monomeric and dimeric forms of activating BRAF mutations. The company has collaborations with BeiGene, Ltd. and GlaxoSmithKline LLC; and license agreements with Pfizer Inc. for nirogacestat and mirdametinib. It also has a license agreement with Katholieke Universiteit Leuven and the Flanders Institute for Biotechnology for a portfolio of novel small molecule inhibitors of the TEA Domain; and Dana-Farber Cancer Institute for a portfolio of novel small molecule inhibitors of Epidermal Growth Factor Receptor. The company was founded in 2017 and is headquartered in Stamford, Connecticut.
fullTimeEmployees§227
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Saqib  Islam J.D.', 'age': 53, 'title': 'CEO & Director', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 1261644, 'exercisedValue': 0, 'unexercisedValue': 20823520}, {'maxAge': 1, 'name': 'Mr. Francis I. Perier Jr., M.B.A.', 'age': 63, 'title': 'Chief Financial Officer', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 710600, 'exercisedValue': 0, 'unexercisedValue': 5204875}, {'maxAge': 1, 'name': 'Dr. Badreddin  Edris Ph.D.', 'age': 36, 'title': 'Chief Operating Officer', 'yearBorn': 1987, 'fiscalYear': 2022, 'totalPay': 998610, 'exercisedValue': 0, 'unexercisedValue': 3336931}, {'maxAge': 1, 'name': 'Dr. L. Mary Smith PH.D.', 'age': 56, 'title': 'Chief Development Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 817172, 'exercisedValue': 0, 'unexercisedValue': 1786699}, {'maxAge': 1, 'name': 'Mr. Bhavesh  Ashar', 'age': 57, 'title': 'Chief Commercial Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 729625, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Michael P. Nofi', 'age': 52, 'title': 'Chief Accounting Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Tai-An  Lin Ph.D.', 'title': 'Chief Scientific Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Kim  Diamond', 'title': 'Vice President of Communications & Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Herschel S. Weinstein J.D.', 'age': 67, 'title': 'General Counsel & Secretary', 'yearBorn': 1956, 'fiscalYear': 2022, 'totalPay': 568638, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Daniel J. Pichl', 'age': 40, 'title': 'Chief People Officer', 'yearBorn': 1983, 'fiscalYear': 2022, 'totalPay': 428510, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§7
boardRisk§8
compensationRisk§9
shareHolderRightsRisk§8
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.812
currency§USD
dateShortInterest§1702598400
forwardEps§-4.68
exchange§NMS
quoteType§EQUITY
shortName§SpringWorks Therapeutics, Inc.
longName§SpringWorks Therapeutics, Inc.
firstTradeDateEpochUtc§1568381400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§b0b16348-0bd4-341b-a3f4-b9f0422c20b3
gmtOffSetMilliseconds§-18000000
targetHighPrice§73.0
targetLowPrice§41.0
targetMeanPrice§54.83
targetMedianPrice§51.0
recommendationMean§1.8
recommendationKey§buy
numberOfAnalystOpinions§6
quickRatio§8.401
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
